Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 49 (RPSAP49) is a processed pseudogene derived from the ribosomal protein SA (RPSA) gene. Pseudogenes in the RPSA family, including RPSAP49, are non-coding DNA segments that arose through retrotransposition and sequence divergence and do not encode a functional protein. While the functional parent gene (RPSA) is involved in ribosomal assembly, laminin binding, cancer metastasis, and prion infection pathways[1][3][5], the pseudogenes are generally considered non-functional remnants. In some cases, pseudogenes may generate non-coding RNAs with regulatory potential, but as of now, RPSAP49 is not established as a biomarker, therapeutic target, or drug-interacting gene[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 49 (RPSAP49).